The activity of myeloperoxidase(MPO) in liver tissue was also determined.
测定肝组织中髓过氧化物酶（MPO）含量。
The myeloperoxidase (MPO) was also assayed to reflect the magnitude of PVEC-PMN adhesion.
测定髓过氧化酶（MPO）活性，反映PVEC粘附PMN的数量。
In fact, myeloperoxidase levels were useful in predicting coronary disease even when cholesterol levels were normal.
事实上，当胆固醇水平正常的情况下，髓过氧化物酶水平对于预测冠心病的发生大有裨益。
The NO content in serum and myeloperoxidase (MPO) content in brain tissue were determined to study the its mechanisms.
同时测定大鼠血清NO及脑组织中MPO含量以探讨氧化苦参碱的作用机制。
Measured in the experiment after the end of the colon length, tissue injury score (HS), myeloperoxidase (MPO) activity.
并在实验结束后测量结肠长度、髓过氧化物酶(mpo)活性、组织损伤评分(HS)。
Potent intracellular bactericidal action may be exerted through the myeloperoxidase - hydrogen peroxide - halide bactericidal system.
强烈的胞内杀菌作用可以通过骨髓过氧化物酶-过氧化氢-卤素杀菌系统发挥威力。
Myeloperoxidase (MPO) is found to be associated with many kinds of diseases, such as inflammation, lung cancer, leukemia, and arteriosclerosis.
髓过氧化物酶与很多疾病有关联，其功能和遗传变异可引起很多疾病，如炎症、肺癌、白血病和心血管疾病。
This article reviews some progresses of myeloperoxidase about its structure, biological function, gene structure, polymorphism and related diseases.
本文就髓过氧化物酶结构、生物学功能、基因结构及多态性与相关疾病的研究进展简要综述。
The histopathological change, myeloperoxidase(MPO) activity and intercellular adhesion molecule-1(ICAM-1) expression were evaluated by various methods.
采用不同方法评价脑组织病理学，变化、髓过氧化物酶（MPO）活性及细胞间粘附因子-1（ICAM-1）表达。
Objective to study the pathological characteristics of leukocyte myeloperoxidase (MPO) deficiency and clinical laboratory diagnostic strategy for this disease.
目的探讨白细胞髓过氧化物酶(mpo)缺陷症的病变特点及临床实验诊断策略。
Results C5 exposed to cathepsin G and elastase generated C5 fragments. C5 fragments stimulated primed neutrophil to release myeloperoxidase(MPO) and lactoferrin.
结果C5暴露于组织蛋白酶G和弹性酶时，产生C5片段，而C5片段能使活化的白细胞释放MPO和乳铁传递蛋白。
Objective to evaluate the monitoring action of the expression myeloperoxidase (MPO) and superoxide dismutase (SOD) activity in the active inflammatory bowel disease (IBD).
目的探讨髓过氧化物酶(MPO)和超氧化物歧化酶(SOD)作为炎症性肠病(IBD)病情活动临床监测指标的价值。
The contents of malondialdehyde(MDA), the activity of superoxidase dismutase(SOD), and the activity of myeloperoxidase(MPO) in intestinal mucosa were measured respectively.
比较各组大鼠肠黏膜丙二醛（MDA）含量、超氧化物歧化酶（SOD）和髓过氧化物酶（MPO）的活性变化；
Objective: to evaluate the monitoring action of the expression myeloperoxidase (MPO) and superoxide dismutase (SOD) activity in the active inflammatory bowel disease (IBD).
目的：研究髓过氧化物酶(MPO)和超氧化物歧化酶(SOD)活性在监测炎症性肠病(IBD)病情活动中的作用。
Objective:To study the clinical and pathologic features of patients with lupus nephritis (LN) whose myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) were positive.
目的：分析伴髓过氧化物酶-抗中性粒细胞胞质抗体（MPO-ANCA）阳性的狼疮性肾炎（LN）患者的临床和病理特点。
Myeloperoxidase in peripheral blood is unique to neutrophils and monocytes, which exists mainly in azurophilic granules. In recent years, it has attracted extensive concern in clinic.
外周血髓过氧化物酶是髓系细胞的特异性标志，主要存在于中性粒细胞和单核细胞的嗜苯胺蓝颗粒中，近几年其在临床工作中的重要性受到广泛关注。
The concentration of malondialdehyde(MDA), superoxide dismutase (SOD) and myeloperoxidase (MPO) in plasma and in liver, kidney and intestine were determined at different times in all groups.
观察血浆丙二醛（MDA）、超氧化物歧化酶（SOD）及组织中丙二醛和髓过氧化酶（MPO）的含量变化，并观察小肠、肝、肺的病理变化。
Results in comparison with group c, colon mucosal damage index (CMDI), myeloperoxidase (MPO) activities and histological scores were significantly decreased in groups a and B after treatment (P0.05).
结果与模型组比较，治疗后a组、B组髓过氧化物酶(mpo)活性及结肠损伤组织学评分(CMDI)均下降(P 0.05)。
Results in comparison with group c, colon mucosal damage index (CMDI), myeloperoxidase (MPO) activities and histological scores were significantly decreased in groups a and B after treatment (P0.05).
结果与模型组比较，治疗后a组、B组髓过氧化物酶(mpo)活性及结肠损伤组织学评分(CMDI)均下降(P 0.05)。
应用推荐